Humana shares slid 13.49% in premarket trading after the federal government proposed a near-flat Medicare Advantage reimbursement rate increase of just 0.09% for plan year 2027 versus Wall Street’s 4%–6% consensus. The unexpected cut threatens to compress Humana’s medical loss ratio, as the company derives roughly 60% of its revenue from Medicare Advantage plans. Competitors UnitedHealth Group, CVS Health and Elevance Health also posted double-digit declines, underscoring systemic margin pressure across the sector. Investors will be watching Humana’s upcoming guidance and cost-containment measures to offset the revenue headwind and preserve its target operating margin of 8%–10%.

Humana announced a first-ever national partnership with Carda Health to offer virtual cardiac and pulmonary rehabilitation to its members. Carda, which treats tens of thousands of patients annually through live-monitored exercise and remote vital sign tracking, will integrate with Humana’s care coordination platform. The program is expected to reduce hospital readmission rates by up to 30% and lower per-member per-month costs by an estimated $150. By eliminating transportation and scheduling barriers, Humana aims to improve patient outcomes while potentially trimming claims expense within its CenterWell subsidiary, which currently serves over 1.2 million Medicare Advantage members through value-based contracts.

In Louisville, Ky., Humana committed $3 million to establish a scholarship fund at Xavier University’s Ochsner College of Medicine to expand Louisiana’s primary care physician workforce. The multi-year program will award up to 75 full-tuition scholarships to medical students who commit to practicing in underserved parishes for at least three years post-residency. Humana expects the initiative to strengthen its provider network in a state where nearly 20% of residents are covered by Medicare Advantage plans, supporting both community health outcomes and long-term membership growth.